JULIA FELDMAN: Open Payments
NPI 1164076899 · FRANKLIN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 87 payments from 14 companies in 2025. Trend: 2023 $1,371 · 2024 $1,190 · 2025 $1,677
Food & beverage: $1,677
| Company | Payments | Amount |
|---|---|---|
| Valinor Pharma, LLC | 22 | $361 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $346 |
| ABBVIE INC. | 9 | $201 |
| Collegium Pharmaceutical, Inc. | 15 | $149 |
| PFIZER INC. | 4 | $97 |
| Averitas Pharma Inc. | 3 | $92 |
| Lilly USA, LLC | 3 | $91 |
| Novo Nordisk Inc | 3 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $67 |
| Azurity Pharmaceuticals, Inc. | 3 | $62 |
Products named: MOVANTIK, RELISTOR, XTAMPZA, UBRELVY, NURTEC ODT, QUTENZA, QULIPTA, JOURNAVX.
Industry payments across MA — which companies pay providers there.
